Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELTROMBOPAG OLAMINE vs ELUXADOLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELTROMBOPAG OLAMINE vs ELUXADOLINE: Safety Overview

Metric ELTROMBOPAG OLAMINE ELUXADOLINE
Total FAERS Reports 16,074 2,353
Deaths Reported 3,457 37
Death Rate 21.5% 1.6%
Hospitalizations 3,284 413
Average Patient Age 56.5 yrs 57.4 yrs
% Female Patients 57.7% 77.7%
FDA Approval Date Apr 18, 2024 Mar 14, 2025
Manufacturer XLCare Pharmaceuticals Inc. Allergan, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription